SCHEMBL2919219

SCHEMBL2919219

COC(=O)c1cc(F)ccc1C(C(=O)O)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
PLA2G2A P14555 3/20 0.41
FFAR4 Q5NUL3 1/20 0.41
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
MAPT P10636 2/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 1/20 0.39
CASP3 P42574 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2918697 0.87 FFAR4 (0.44) SLC6A4SLC6A3PLA2G2AFFAR4KDM4E
SCHEMBL10154075 0.87 SLC6A4 (0.43) SLC6A4SLC6A3PLA2G2AFFAR4KDM4E
SCHEMBL20601709 0.83 SLC6A4 (0.45) SLC6A4SLC6A3PLA2G2AFFAR4KDM4E
SCHEMBL14084345 0.83 SLC6A4 (0.49) SLC6A4SLC6A3PLA2G2AKDM4EALDH1A1
SCHEMBL30296763 0.78 SLC6A4 (0.41) SLC6A4SLC6A3PLA2G2AFFAR4KDM4E
SCHEMBL26620169 0.78 SLC6A4 (0.41) SLC6A4SLC6A3PLA2G2AFFAR4KDM4E
SCHEMBL30301996 0.77 SLC6A4 (0.51) SLC6A4SLC6A3PLA2G2AFFAR4KDM4E
SCHEMBL2708451 0.77 SLC6A4 (0.51) SLC6A4SLC6A3PLA2G2AFFAR4KDM4E
SCHEMBL23729962 0.76 KEAP1 (0.52) SLC6A4SLC6A3PLA2G2AFFAR4KDM4E
SCHEMBL27268096 0.76 SLC6A4 (0.39) SLC6A4SLC6A3PLA2G2AFFAR4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478624-B1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2010-09-08 EP disclosed
US-7709500-B2 Chemical compounds ASTRAZENECA AB (SE) 2010-05-04 US disclosed
US-20050107428-A1 Chemical compounds ASTRAZENECA AB (SE) 2005-05-19 US disclosed
EP-1478624-A1 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2004-11-24 EP disclosed
WO-2003068743-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2003-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107428-A1 Chemical compounds CCR10, CCR3, CXCR5 SLC6A4 2650/4885SLC6A3 2949/4885PLA2G2A 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.